Nurse intervention in the management of chemotherapy-induced peripheral neuropathy: scoping review
DOI:
https://doi.org/10.29352/mill0221e.43854Keywords:
nurse’s role; peripheral nervous system diseases; antineoplastic agents; neoplasms; cancer survivorsAbstract
Introduction: As the second leading cause of death, neoplasms are treated with aggressive therapies that have undesirable side effects, such as peripheral neuropathy. This can include motor, sensory, and autonomic symptoms, with a significant impact on the quality of life of patients and survivors. Currently, there are no internationally agreed preventive or curative strategies available.
Objective: To map nursing interventions for the management of chemotherapy-induced peripheral neuropathy (CIPN) in cancer patients.
Methods: A scoping review was conducted using the methodology proposed by the Joanna Briggs Institute (JBI), drawing on the PubMed and CINAHL databases, as well as Portugal's open access scientific repository (RCAAP). No time or language restrictions were applied.
Results: Sixteen studies were included, allowing for the identification and systematization of nursing interventions in the areas of assessment, patient and caregiver training, symptom management, and referral to other professionals.
Conclusion: The implementation of effective strategies for managing NPIQ promotes healthy readaptation and is a key component of the functional content of nursing professionals. A reorganisation of the healthcare system, traditionally focused on acute episodes, is needed to integrate cancer morbidity and the sequelae of treatments, with effective coordination between specialised and primary care. The compilation of the various nursing interventions provides a starting point for the development of a guidance manual for both patients and informal and professional caregivers.
Downloads
References
Bakitas, M. A. (2007). The experience of chemotherapy-induced peripheral neuropathy. Nursing Research, 56(5), 323–331. https://doi.org/10.1097/01.NNR.0000289503.22414.79
Baptista, S. C. (2022). Pessoa com neuropatia periférica induzida pela quimioterapia: Da avaliação aos registos de enfermagem. [Relatório de estágio, Escola Superior de Enfermagem de Coimbra]. Repositório ESEnfC. http://web.esenfc.pt/?url=N7ZxUMog
Çelik, A., & Usta Yeşilbalkan, Ö. (2024). Knowledge levels of oncology nurses regarding evidence-based practices in the assessment and management of chemotherapy-induced peripheral neuropathy. Asia-Pacific Journal of Oncology Nursing, 11(10), 100581. https://doi.org/10.1016/j.apjon.2024.100581
Cunha, M., Tavares, I., & Costa-Pereira, J. T. (2024). Centralizing the Knowledge and Interpretation of pain in chemotherapy-induced peripheral neuropathy: A paradigm shift towards brain-centric approaches. Brain Sciences, 14(7). https://doi.org/10.3390/brainsci14070659
European Oncology Nursing Society. (2012). Neuropatia periférica. Euro-PEP. Oncology Nursing Society. https://doi.org/10.29327/5408261.1-8
Fan, J. X., Hu, Y. C., Chen, X., & Li, Y. (2023). Nursing dilemmas in chemotherapy-induced peripheral neuropathy: A qualitative study of a tertiary hospital in China. Journal of Pain Research, 16, 2299–2308. https://doi.org/10.2147/JPR.S409580
Ferlay, J., Ervik, M., Lam, F., Laversanne, M., Colombet, M., Mery, L., Piñeros, M., Znaor, A., Soerjomataram, I., & Bray, F. (2024). Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer.
Fitch, M. I., Nicoll, I., & Lockwood, G. (2020). Cancer survivor’s perspectives on the major challenge in the transition to survivorship. Patient Education and Counseling, 103(11), 2361–2367. https://doi.org/10.1016/j.pec.2020.04.018
Garpenhag, L., Halling, A., Calling, S., Rosell, L., & Larsson, A.-M. (2024). “Being ill was the easy part”: Exploring cancer survivors reactions to perceived challenges in engaging with primary healthcare. International Journal of Qualitative Studies on Health and Well-Being, 19(1), 2361492. https://doi.org/10.1080/17482631.2024.2361492
Gerbrecht, B.-M. (2003). Current Canadian experience with capecitabine: Partnering with patients to optimize therapy. Cancer Nursing, 26(2), 161–167. https://doi.org/10.1097/00002820-200304000-00011
He, S., Wang, M., Zhang, L., Zhu, P., Zhou, J., Fang, Z., & Shi, L. (2024). Impact of comprehensive nursing on hand-foot syndrome caused by oral capecitabine in breast cancer patients. African Journal of Reproductive Health, 28(9), 163–171. https://doi.org/10.29063/ajrh2024/v28i9.15
Hertz, D. L., Tofthagen, C., & Faithfull, S. (2021). Predisposing factors for the development of chemotherapy-induced peripheral neuropathy (CIPN). M. Lustberg & C. Loprinzi (Eds.), Diagnosis, management and emerging strategies for chemotherapy-Induced neuropathy (19–51). Springer Cham. https://doi.org/doi.org/10.1007/978-3-030-78663-2_2
Jones, K. F., Wechsler, S., Zulewski, D., & Wood, L. (2022). Pharmacological and nonpharmacological management of chemotherapy-induced peripheral neuropathy: A scoping review of randomized controlled trials. Journal of Palliative Medicine, 25(6), 964–995. https://doi.org/10.1089/jpm.2021.0512
Kanzawa-Lee, G. A. (2020). Chemotherapy-induced peripheral neuropathy: Nursing implications. Journal of Infusion Nursing, 43(3), 155–166. https://doi.org/10.1097/NAN.0000000000000368
Kanzawa-Lee, G., Krauss, J. C., & Knoerl, R. (2024). Exploring chemotherapy-induced peripheral neuropathy management practice patterns among oncology clinicians. Seminars in Oncology Nursing, 40(5), 151685. https://doi.org/10.1016/j.soncn.2024.151685
Klafke, N., Bossert, J., Kröger, B., Neuberger, P., Heyder, U., Layer, M., Winkler, M., Idler, C., Kaschdailewitsch, E., Heine, R., John, H., Zielke, T., Schmeling, B., Joy, S., Mertens, I., Babadag-Savas, B., Kohler, S., Mahler, C., Witt, C. M., … Stolz, R. (2023). Prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN) with non-pharmacological interventions: Clinical recommendations from a systematic scoping review and an expert consensus process. Medical Sciences, 11(15). https://doi.org/10.3390/medsci11010015
Knoerl, R. (2021). CE: Chemotherapy-induced peripheral neuropathy. The American Journal of Nursing, 121(4), 26–30. https://doi.org/10.1097/01.NAJ.0000742060.56042.e7
Lee, K. T., Bulls, H. W., Hoogland, A. I., James, B. W., Colon-Echevarria, C. B., & Jim, H. S. L. (2024). Chemotherapy-induced peripheral neuropathy (CIPN): A narrative review and proposed theoretical model. Cancers, 16(14), 2571. https://doi.org/10.3390/cancers16142571
Ling, X., Minfen, X., Wang, J., & Zhagn, W. (2019). Analysis on risk factors and nursing countermeasures for hand and foot syndrome caused by apatinib mesylate. Chinese Nursing Research, 33(23), 4049-4054. https://doi.org/doi:10.12102/j.issn.1009-6493.2019.23.010
Magalhães, B., Carla, F., Lima, L., Martinez-Galiano, J. M., & Célia, S. (2020). Cancer patients’ experiences on self-management of chemotherapy treatment-related symptoms: A systematic review and thematic synthesis. European Journal of Oncology Nursing, 49. https://doi.org/10.1016/j.ejon.2020.101837
Mahfouz, F. M. (2023). Chemotherapy-induced peripheral neuropathy (CIPN): Classification and investigation of assessment tools to identify different CIPN subgroups [Tese de Doutoramento]. University of Sydney.
Mattar, M., Umutoni, F., Hassan, M. A., Wamburu, M. W., Turner, R., Patton, J. S., Chen, X., & Lei, W. (2024). Chemotherapy-induced peripheral neuropathy: A recent update on pathophysiology and treatment. Life, 14(8), 1–25. https://doi.org/10.3390/life14080991
Misawa, S., Denda, T., Kodama, S., Suzuki, T., Naito, Y., Kogawa, T., Takada, M., Hino, A., Shiosakai, K., & Kuwabara, S. (2025). One-year incidence of chemotherapy-induced peripheral neuropathy in oxaliplatin- or taxane-based chemotherapy: A multicenter, prospective registry study (MiroCIP study). Expert Opinion on Pharmacotherapy, 26(3), 335–344. https://doi.org/10.1080/14656566.2025.2455445
Mizrahi, D., Goldstein, D., Kiernan, M. C., Robinson, L., Pitiyarachchi, O., McCullough, S., Mendoza-Jones, P., Grimison, P., Boyle, F., & Park, S. B. (2022). Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy. Supportive Care in Cancer, 30(7), 5965–5974. https://doi.org/10.1007/s00520-022-07024-3
Molassiotis, A., Cheng, H. L., Leung, K. T., Li, Y. C., Wong, K. H., Au, J. S. K., Sundar, R., Chan, A., Ng, T. R. De, Suen, L. K. P., Chan, C. W., Yorke, J., & Lopez, V. (2019). Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy. Brain and Behavior, 9(6), 1–10. https://doi.org/10.1002/brb3.1312
Nail, L. M. (2001). Long-term persistence of symptoms. Seminars in Oncology Nursing, 17(4), 249–254. https://doi.org/10.1053/sonu.2001.27916
Nicholas, C., Siano, S., & Knowlton, S. E. (2024). Evidence-based physiatry diagnosing and treating chemotherapy-induced peripheral neuropathy. American Journal of Physical Medicine and Rehabilitation, 103(8), 745–746. https://doi.org/10.1097/PHM.0000000000002516
Organisation for Economic Co-operation and Development. (2023). Perfil sobre cancro por país: Portugal 2023. OECD Publishing. https://doi.org/10.1787/40186a6b-pt
Pereira, P. P., Pedroso, R. dos S., & Ribeiro, M. Â. (2019). Identificação, prevenção e tratamento da síndrome mão-pé induzida por quimioterapia: Revisão sistemática. Revista Brasileira de Cancerologia, 65(4). https://doi.org/10.32635/2176-9745.rbc.2019v65n4.363
Preti, K., & Davis, M. E. (2024). Chemotherapy-induced peripheral neuropathy: Assessment and treatment strategies for advanced practice providers. Clinical Journal of Oncology Nursing, 28(4), 351–357. https://doi.org/10.1188/24.CJON.351-357
Salgado, T. M., Quinn, C. S., Krumbach, E. K., Wenceslao, I., Gonzalez, M., Reed, H. L., Syverson, J. G., Etz, R. S., Vangipuram, K., Barker, M. R., Henry, N. L., Farris, K. B., & Hertz, D. L. (2020). Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: A qualitative study. Supportive Care in Cancer, 28(9), 4163–4172. https://doi.org/10.1007/s00520-019-05254-6
Sawicki, O. A., Mueller, A., Klaaßen-Mielke, R., Glushan, A., Gerlach, F. M., Beyer, M., Wensing, M., & Karimova, K. (2021). Strong and sustainable primary healthcare is associated with a lower risk of hospitalization in high risk patients. Scientific Reports, 11(1), 1–10. https://doi.org/10.1038/s41598-021-83962-y
Siddiq, N., & Lustberg, M. (2022). Chemotherapy-induced peripheral neuropathy. Elsevier, 6. https://doi.org/10.1016/B978-0-12-820472-6.00109-2
Son, H.-S., Lee, W. Y., Lee, W.-S., Yun, S. H., & Chun, H.-K. (2009). Compliance and effective management of the hand-foot syndrome in colon cancer patients receiving capecitabine as adjuvant chemotherapy. Yonsei Medical Journal, 50(6), 796–802. https://doi.org/10.3349/ymj.2009.50.6.796
Svindseth, J., Ellingsen, S., & Bruvik, F. (2023). Living with chemotherapy-induced peripheral neuropathy. Sykepleien Forskning, 18(93305), e-93305, e-93305. https://doi.org/10.4220/sykepleienf.2023.93305en
Tanay, M. A., & Armes, J. (2019). Lived experiences and support needs of women who developed chemotherapy-induced peripheral neuropathy following treatment for breast and ovarian cancer. European Journal of Cancer Care, 28(3), e13011. https://doi.org/10.1111/ecc.13011
Tanay, M. A. L., Robert, G., Rafferty, A. M., Moss-Morris, R., & Armes, J. (2022). Clinician and patient experiences when providing and receiving information and support for managing chemotherapy-induced peripheral neuropathy: A qualitative multiple methods study. European Journal of Cancer Care, 31(1), e13517. https://doi.org/10.1111/ecc.13517
Tofthagen (2010). Patient perceptions associated with chemotherapy-induced peripheral neuropathy. Clinical Journal of Oncology Nursing, 14(3), e22-e28. https://doi.org/10.1188/10.CJON.E22-E28
Tofthagen, C., McAllister, R. D., & McMillan, S. C. (2011). Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin. Clinical Journal of Oncology Nursing, 15(2), 182–188. https://doi.org/10.1188/11.CJON.182-188
Tofthagen, C., Visovsky, C. M., & Hopgood, R. (2013). Chemotherapy-induced peripheral neuropathy: An algorithm to guide nursing management. Clinical Journal of Oncology Nursing, 17(2), 138–144. https://doi.org/10.1188/13.CJON.138-144
Vidinha, T., Ferreira, A., Gonçalves, M., Ferraz, L., & Marques, A. (2024). Evitamento do enfermeiro ao processo de capacitação do cuidador informal: perspetivas sobre os fatores condicionantes . Millenium - Journal of Education, Technologies, and Health, 2(23), e33593. https://doi.org/10.29352/mill0223.33593
Wachlin, M., Coughlin, R., Lynch, M. P., Bass, M., & Colgate, S. (2024). Impacting chemotherapy-induced peripheral neuropathy through nurse navigation and clinical pathway. Journal of Oncology Navigation & Survivorship, 15(7). https://shre.ink/5Elk
Wampler, M. A., Hamolsky, D., Hamel, K., Melisko, M., & Topp, K. S. (2005). Case report: Painful peripheral neuropathy following treatment with docetaxel for breast cancer. Clinical Journal of Oncology Nursing, 9(2), 189–193. https://doi.org/10.1188/05.cjon.189-193
Was, H., Borkowska, A., Bagues, A., Tu, L., Liu, J. Y. H., Lu, Z., Rudd, J. A., Nurgali, K., & Abalo, R. (2022). Mechanisms of chemotherapy-induced neurotoxicity. Frontiers in Pharmacology, 13, 1–32. https://doi.org/10.3389/fphar.2022.750507
Wickham, R. (2006). Chemotherapy-induced peripheral neuropathy: A review and implications for oncology nursing practice. Clinical Journal of Oncology Nursing, 11(3), 361–376. https://doi.org/10.1188/07.CJON.361-376
Wu, S., Xiong, T., Guo, S., Zhu, C., Jing, H., & Wang, S. (2023). An up-to-date view of paclitaxel-induced peripheral neuropathy. Journal of Cancer Research and Therapeutics, 19, 1501–1508. https://doi.org/10.4103/jcrt.jcrt_1982_22
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Millenium - Journal of Education, Technologies, and Health
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who submit proposals for this journal agree to the following terms:
a) Articles are published under the Licença Creative Commons (CC BY 4.0), in full open-access, without any cost or fees of any kind to the author or the reader;
b) The authors retain copyright and grant the journal right of first publication, allowing the free sharing of work, provided it is correctly attributed the authorship and initial publication in this journal;
c) The authors are permitted to take on additional contracts separately for non-exclusive distribution of the version of the work published in this journal (eg, post it to an institutional repository or as a book), with an acknowledgment of its initial publication in this journal;
d) Authors are permitted and encouraged to publish and distribute their work online (eg, in institutional repositories or on their website) as it can lead to productive exchanges, as well as increase the impact and citation of published work
Documents required for submission
Article template (Editable format)
